APGE
APOGEE THERAPEUTICS Buyout Closes as Shares Head for Delisting
An 8-K filing shows Apogee Therapeutics has completed a change-of-control transaction, replaced its board and recapitalized to just 1,000 shares.
APGE
An 8-K filing shows Apogee Therapeutics has completed a change-of-control transaction, replaced its board and recapitalized to just 1,000 shares.
DH
A special committee of independent directors confirmed a non-binding all-cash proposal from Advent International for all shares it does not already own.
VRT
Vertiv Corporation agreed to acquire Utility Innovation Holdings via merger, with a base purchase price of $1.45 billion plus an earnout, per an 8-K filing.